Erik Trock-Jansen
Algemeen Directeur bij NOVIMMUNE SA
Profiel
Erik Trock-Jansen is currently the Chief Executive Officer at NovImmune SA since 2018.
Prior to this, he was the Chairman at Tytex A and the President at Vernal AG.
Actieve functies van Erik Trock-Jansen
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVIMMUNE SA | Algemeen Directeur | 01-08-2018 |
Eerdere bekende functies van Erik Trock-Jansen
| Bedrijven | Functie | Einde |
|---|---|---|
Tytex A/S
 Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Voorzitter | - |
Vernal AG
 Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Vernal AG
Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | Process Industries |
Tytex A/S
Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Process Industries |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |